A life without asthma

The global health impact of Peptinnovate’s first in class immune regulating medicines promises to be extremely significant. Our goal is to benefit patients to experience periods of remission without medication and for payers and healthcare providers to benefit from reduced hospitalisations and other costs.

Unique Selling Points

PIN201104 offers 3 key clinical unique selling propositions over current treatments as well as a margin opportunity based on the current pricing models: